The Diagnostic Value of Serum Glypican-3 in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Journal Title: International Journal of Health & Medical Research - Year 2023, Vol 2, Issue 09
Abstract
Background and aim: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. It is curable in the early stages but has a poor prognosis when advanced. Current diagnostic protocols for the early stages of HCC are inefficient. Serum Glypican-3 (GPC-3) is a promising serum tumour marker in diagnosing HCC, and its diagnostic value has been explored in various studies. The outcomes, however, continue to be inconsistent and controversial. This systematic review and meta-analysis aimed to investigate the diagnostic accuracy of serum GPC-3 in hepatocellular carcinoma. This study included recent papers not captured in previous meta-analyses. Method: PUBMED, MEDLINE, Cochrane Library, and CINAHL databases were systematically searched according to preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies guidelines. Studies on the diagnostic accuracy of serum GPC-3 in HCC were selected. The Quality assessment of diagnostic accuracy studies 2 (QUADAS-2) tools were used to assess the quality of selected studies. Sensitivity, specificity, and other diagnostic parameters were pooled using the random effect model. The Summary receiver operating characteristic (sROC) was used to summarise the diagnostic accuracy of Serum GPC-3. Results: Eleven studies were included in this systematic review. The pooled sensitivity, specificity, and 95% confidence intervals (CIs) were 0.60 (0.57-0.62) and 0.67(0.64-0.70), respectively. The pooled positive and negative likelihood ratios and 95% CIs were 2.11 (1.51-2.93) and 0.59 (0.51-0.68), respectively; the pooled diagnostic odds ratio and the 95% CI were 4.07 (2.37-6.98), the area under the sROC curve was 0.7194. Conclusion: This meta-analysis has shown that Serum GPC-3 has an acceptable diagnostic value in diagnosing HCC compared to benign chronic liver diseases. A higher-quality study with a larger sample size is necessary to thoroughly assess the diagnostic utility of serum GPC-3.
Authors and Affiliations
Arinze I. Aninworie, MD, MSc
Keywords
Related Articles
- EP ID EP731145
- DOI 10.58806/ijhmr.2023.v2i9n05
- Views 65
- Downloads 0
The Role of Ursodeoxycholic Acid After Bariatric Surgery
Background: currently obesity and overweight are two of the major public health problems worldwide, which haunts the health of more and more young people around the world, as this problem advances so does medicine, treat...
Pathogenic Bacteria Associated with Urinary Tract Infections
UTIs, which are also commonly referred to as urinary tract infections, are a common and sometimes reoccurring infection that can range from happening on their own to posing a severe risk to the health of the patient. Thi...
The Role of Swimming Training in Preventing Preeclampsia During Pregnancy
Introduction: Preeclampsia is a serious complication that affects pregnant women and poses risks to both maternal and fetal health. Understanding the relationship between swimming training and the risk of preeclampsia is...
Improving Nurses’ Proficiency In Providing Nursing Care For Pediatric Tonsillectomy
Objective: Tonsillectomy is the most common surgery in the field of ENT. Pain is the most common post tonsillectomy complaint. Considering the importance of nursing cares in relieving post-surgery pain in general and pos...
The Relationship of Response Time and Therapeutic Communication Capability of Nurses on Patient Satisfaction
Dissatisfaction with health services is a situation where consumer expectations are not the same or higher than the performance received from the service (Kotler and Keller, 2018). Factors that can cause patient dissatis...